Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vagus nerve stimulation for partial seizures.

M D Privitera1, T E Welty, D M Ficker

  • 1Department of Neurology, University of Cincinnati Medical Center (525), 231 Albert B. Sabin Way, Cincinnati, Ohio 45267-0525, USA. michael.privitera@uc.edu

The Cochrane Database of Systematic Reviews
|March 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.

British journal of cancer·2011
Same author

The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia.

Acta neurologica Scandinavica·2011
Same author

Risk of adverse events on epilepsy monitoring units: a survey of epilepsy professionals.

Epilepsy & behavior : E&B·2011
Same author

Naloxone in the management of hepatic encephalopathy.

Journal of clinical pharmacy and therapeutics·2010
Same author

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.

Acta neurologica Scandinavica·2005
Same author

Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.

Neurology·2005

Vagus nerve stimulation (VNS) effectively reduces seizure frequency in drug-resistant epilepsy. This adjunctive treatment is well-tolerated, with manageable side effects like hoarseness.

Area of Science:

  • Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Vagus nerve stimulation (VNS) is an emerging adjunctive therapy for refractory epilepsy.
  • This review synthesizes evidence on VNS for drug-resistant partial seizures.

Purpose of the Study:

  • To evaluate the efficacy of high-level VNS compared to low-level stimulation.
  • To assess treatment withdrawal rates and adverse effects associated with VNS.

Main Methods:

  • Systematic review of randomized, double-blind controlled trials.
  • Searched Cochrane Epilepsy Group, MEDLINE, and Cochrane Controlled Trials Register (up to Oct 2000).
  • Assessed seizure frequency reduction, treatment withdrawal, and side effects.

Main Results:

Related Experiment Videos

  • High-level VNS significantly improved seizure reduction (OR 1.93) compared to low-level stimulation.
  • VNS was well-tolerated, with rare treatment withdrawals between groups.
  • Adverse effects included hoarseness, cough, pain, paresthesia, and dyspnea, primarily associated with implantation and stimulation.

Conclusions:

  • Vagus nerve stimulation is an effective and well-tolerated adjunctive treatment for partial seizures.
  • Reported adverse effects are manageable, with low dropout rates.
  • VNS did not show typical central nervous system side effects associated with antiepileptic drugs.